A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Manylion Llyfryddiaeth
Prif Awdur:	Islam, Saidul
Awduron Eraill:	Sharmin, Shahana
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	Brac University 2022
Pynciau:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Mynediad Ar-lein:	http://hdl.handle.net/10361/17308

Eitemau Tebyg

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
gan: Karim, Azrin
Cyhoeddwyd: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
gan: Meem, Manila
Cyhoeddwyd: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
gan: Alam, Tahera
Cyhoeddwyd: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
gan: Jahan, Nusrat
Cyhoeddwyd: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
gan: Ahmed, Nafisa
Cyhoeddwyd: (2023)

Immunotherapy in the Management of Lung Cancer
gan: Tasnim, Humayra
Cyhoeddwyd: (2022)

A review on triple-negative breast cancer and its potential treatment
gan: Niasa, Jannatul Ferdous
Cyhoeddwyd: (2023)

Stem cells as therapeutic carrier in cancer treatment
gan: Anika, Mysha Yeasmin
Cyhoeddwyd: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
gan: Hasan, Amit
Cyhoeddwyd: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
gan: Chakraborty, Anuradha
Cyhoeddwyd: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
gan: Khan, Muidul Hasan
Cyhoeddwyd: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
gan: Roy, Hredita
Cyhoeddwyd: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
gan: Emon, Kamrul Hasan
Cyhoeddwyd: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
gan: Mirza, Maisa Tasnim
Cyhoeddwyd: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
gan: Khan, Rezia Nowrin
Cyhoeddwyd: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
gan: Nuha, Nabiha Tahsin
Cyhoeddwyd: (2024)

Role of statins as antagonists of SPARC in gastric cancer
gan: Shahmat, Rad
Cyhoeddwyd: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
gan: Sorno, Rubina Haque
Cyhoeddwyd: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
gan: Ratu, Tabassum
Cyhoeddwyd: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
gan: Choki, Kinley
Cyhoeddwyd: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
gan: Razna, Amrin Islam
Cyhoeddwyd: (2019)

A comprehensive review on drug repurposing in cancer treatment
gan: Sarkar, Onusree
Cyhoeddwyd: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
gan: Mahaleka, Aarshi
Cyhoeddwyd: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
gan: Shaikat, Mahdi Mubin
Cyhoeddwyd: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
gan: Hasan, Sakib
Cyhoeddwyd: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
gan: Nawar, Anika
Cyhoeddwyd: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
gan: Deeba, Maliha Tasnim
Cyhoeddwyd: (2018)

Targeting BRAFV600E in the treatment of CRC
gan: Roja, Mashwiyat Samrin
Cyhoeddwyd: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
gan: Alam, Kazi Tasnuva
Cyhoeddwyd: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
gan: Rahman, Sanjida
Cyhoeddwyd: (2024)

Biosimilar in lymphoma treatment
gan: Tanisha, Mehrin Haque
Cyhoeddwyd: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
gan: Khondokar, Faiza
Cyhoeddwyd: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
gan: Islam, Nahidul
Cyhoeddwyd: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
gan: Beruni, Sajid Mahmud Al
Cyhoeddwyd: (2022)

Oncogenes: new targets in cancer treatment
gan: Chowdhury, Waseka Shams
Cyhoeddwyd: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
gan: Muntaha, Habibatul
Cyhoeddwyd: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
gan: Haque, Mushfiqul
Cyhoeddwyd: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Karim, Samia Binte
Cyhoeddwyd: (2024)